跳至主要内容
临床试验/CTRI/2013/12/004199
CTRI/2013/12/004199招募中2 期

Validation of a Unani Pharmacopoeial formulation in Waja ul Mafasil (Rheumatoid Arthritis)

Monetary Support Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex in the age group of 20-60
  • Patients fulfilling the ACR criteria for rheumatoid arthritis i.e the 2010 American College of Rheumatology/European League Against Rheumatism classification Criteria for rheumatoid arthritis

排除标准

  • Patients having Gout, or complicated rheumatoid arthritis associated with deformity.
  • Abnormality in any investigation done at baseline (SGOT, SGPT and ALP,Sr Creatinine, B.Urea would be considered abnormal if raised 2 ½ times the normal value )
  • Overweight subjects â?? BMI 35
  • Disorders requiring long term treatment
  • Drug addicts ( Alcohol, drugs )
  • Pregnant and lactating women

研究者

发起方
Monetary Support Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验